📣 VC round data is live. Check it out!
- Public Comps
- Mouwasat
Mouwasat Valuation Multiples
Discover revenue and EBITDA valuation multiples for Mouwasat and similar public comparables like Asker Healthcare Group, Medicover, Kpj Healthcare, Global Health and more.
Mouwasat Overview
About Mouwasat
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue.
Founded
1997
HQ

Employees
4.1K
Website
Sectors
Financials (LTM)
EV
$4B
Valuation Multiples
Start free trialMouwasat Financials
Mouwasat reported last 12-month revenue of $904M and EBITDA of $306M.
In the same LTM period, Mouwasat generated $378M in gross profit, $306M in EBITDA, and $222M in net income.
Revenue (LTM)
Mouwasat P&L
In the most recent fiscal year, Mouwasat reported revenue of $864M and EBITDA of $308M.
Mouwasat is profitable as of last fiscal year, with gross margin of 42%, EBITDA margin of 36%, and net margin of 26%.
Financial data powered by Morningstar, Inc.
Mouwasat Stock Performance
Mouwasat has current market cap of $3B, and enterprise value of $4B.
Market Cap Evolution
Mouwasat's stock price is $17.41.
Mouwasat share price decreased by 0.7% in the last 30 days, and by 13.5% in the last year.
Mouwasat has an EPS (earnings per share) of $1.10.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $3B | -1.9% | -0.7% | -10.2% | -13.5% | $1.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMouwasat Valuation Multiples
Mouwasat trades at 4.0x EV/Revenue multiple, and 12.0x EV/EBITDA.
EV / Revenue (LTM)
Mouwasat Financial Valuation Multiples
As of June 2, 2026, Mouwasat has market cap of $3B and EV of $4B.
Mouwasat has a P/E ratio of 15.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mouwasat Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Mouwasat Margins & Growth Rates
Mouwasat grew revenue by 12% and EBITDA by 3% in the last fiscal year.
In the most recent fiscal year, Mouwasat reported gross margin of 42%, EBITDA margin of 36%, and net margin of 26%.
Mouwasat Margins
Mouwasat Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Mouwasat Operational KPIs
Mouwasat's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Mouwasat's Rule of 40 is 45% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mouwasat's Rule of X is 62% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Mouwasat Competitors
Mouwasat competitors include Asker Healthcare Group, Medicover, Kpj Healthcare, Global Health, Meinian Onehealth, Concentra Group, Option Care Health, Krishna Institute, Aster DM Healthcare and LifeStance Health.
Most Mouwasat public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.1x | 2.0x | 17.6x | 16.7x | |||
| 1.8x | 1.7x | 10.9x | 10.4x | |||
| 3.9x | 3.8x | 16.0x | 16.1x | |||
| 7.1x | 7.0x | 30.9x | 32.8x | |||
| 2.5x | 2.4x | 11.8x | 13.2x | |||
| 2.4x | 2.4x | 12.3x | 11.8x | |||
| 0.8x | 0.8x | 9.1x | 9.1x | |||
| 8.8x | 8.4x | 41.8x | 40.5x | |||
This data is available for Pro users. Sign up to see all Mouwasat competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mouwasat
| When was Mouwasat founded? | Mouwasat was founded in 1997. |
| Where is Mouwasat headquartered? | Mouwasat is headquartered in Saudi Arabia. |
| How many employees does Mouwasat have? | As of today, Mouwasat has over 4K employees. |
| Is Mouwasat publicly listed? | Yes, Mouwasat is a public company listed on Tadawul. |
| What is the stock symbol of Mouwasat? | Mouwasat trades under 4002 ticker. |
| When did Mouwasat go public? | Mouwasat went public in 2009. |
| Who are competitors of Mouwasat? | Mouwasat main competitors include Asker Healthcare Group, Medicover, Kpj Healthcare, Global Health, Meinian Onehealth, Concentra Group, Option Care Health, Krishna Institute, Aster DM Healthcare, LifeStance Health. |
| What is the current market cap of Mouwasat? | Mouwasat's current market cap is $3B. |
| What is the current revenue of Mouwasat? | Mouwasat's last 12 months revenue is $904M. |
| What is the current revenue growth of Mouwasat? | Mouwasat revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Mouwasat? | Current revenue multiple of Mouwasat is 4.0x. |
| What is the current EBITDA of Mouwasat? | Mouwasat's last 12 months EBITDA is $306M. |
| What is Mouwasat's EBITDA margin? | Mouwasat's last 12 months EBITDA margin is 34%. |
| What is the current EV/EBITDA multiple of Mouwasat? | Current EBITDA multiple of Mouwasat is 12.0x. |
| What is the current FCF of Mouwasat? | Mouwasat's last 12 months FCF is $123M. |
| What is Mouwasat's FCF margin? | Mouwasat's last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Mouwasat? | Current FCF multiple of Mouwasat is 29.7x. |
| How many companies Mouwasat has acquired to date? | Mouwasat hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Mouwasat has invested to date? | Mouwasat hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Mouwasat
Lists including Mouwasat
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.